Pages that link to "Q45848174"
Jump to navigation
Jump to search
The following pages link to HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope (Q45848174):
Displaying 50 items.
- Pathogenesis of human immunodeficiency virus infection (Q24634681) (← links)
- Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding (Q24644617) (← links)
- Sulfation of the human immunodeficiency virus envelope glycoprotein (Q24647955) (← links)
- An algorithm for mapping positively selected members of quasispecies-type viruses (Q24797088) (← links)
- A brief history of the global effort to develop a preventive HIV vaccine (Q26851165) (← links)
- Crystal Structure of the HIV-2 Neutralizing Fab Fragment 7C8 with High Specificity to the V3 Region of gp125 (Q27667679) (← links)
- The antigenic structure of the HIV gp120 envelope glycoprotein (Q28274698) (← links)
- The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates (Q28282895) (← links)
- Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion (Q28368943) (← links)
- Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein (Q28646850) (← links)
- Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 (Q29619512) (← links)
- Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design. (Q30342455) (← links)
- Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry (Q30393415) (← links)
- Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins (Q30407161) (← links)
- Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate (Q30417262) (← links)
- Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides (Q33560772) (← links)
- Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain (Q33564746) (← links)
- A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus (Q33564946) (← links)
- Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization (Q33567984) (← links)
- An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. (Q33570776) (← links)
- Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120 (Q33571605) (← links)
- Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes (Q33578652) (← links)
- Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees (Q33582665) (← links)
- 95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor (Q33645518) (← links)
- Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles (Q33660809) (← links)
- Aminosugar derivatives as potential anti-human immunodeficiency virus agents (Q33681820) (← links)
- Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits (Q33825327) (← links)
- Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. (Q33832289) (← links)
- Turning a corner on HIV neutralization? (Q33878662) (← links)
- Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain (Q33880904) (← links)
- Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous (Q33927239) (← links)
- Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates (Q33933855) (← links)
- Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events (Q33936268) (← links)
- Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein (Q33937274) (← links)
- Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160 (Q34171623) (← links)
- Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein (Q34301897) (← links)
- Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers (Q34313555) (← links)
- Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus (Q34332284) (← links)
- Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion (Q34335264) (← links)
- Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells (Q34350730) (← links)
- Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine (Q34373003) (← links)
- Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide (Q34632476) (← links)
- Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack (Q34636237) (← links)
- Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. (Q34640420) (← links)
- Human immunodeficiency virus (HIV) antigens: structure and serology of multivalent human mucin MUC1-HIV V3 chimeric proteins (Q34867076) (← links)
- Prospects for an HIV vaccine: conventional approaches and DNA immunization (Q35042496) (← links)
- The blood group antigen-related glycoepitopes: Key structural determinants in immunogenesis and AIDS pathogenesis (Q35160742) (← links)
- Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1 (Q35554157) (← links)
- Identifying epitopes of HIV-1 that induce protective antibodies (Q35708836) (← links)
- A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B. (Q35828898) (← links)